fbpx

Thought Leadership

When it comes to thought leadership and staying informed, we’ve got you covered. See below for recent articles, webinars, and downloadable resources available.

Want updates like these sent directly to your inbox?

Subscribe to our Newsletters

340B 8.21.20

Additional Manufacturers Seek Contract Pharmacy Data and Place Restrictions on 340B Programs

AstraZeneca distributed letters recently that as of October 1, 2020, 340B pricing will be available only through “a single contract pharmacy for those covered entities that do not maintain their […]

Learn More
340B Reimbursement Update

Medicare Part B Reimbursement Cuts To 340B Hospitals

In 2018, the Center for Medicare & Medicaid Services (CMS) implemented a change in reimbursement for DSHs, RRCs, and non-rural SCHs for Medicare Part B drugs obtained through the 340B […]

Learn More
2021 Grantee recertification

2020 Hospital 340B Recertification Reminder

The Health Resources and Services Administration has set the annual recertification of eligibility for 340B drug discounts for hospitals to begin August 17, 2020 and end September 14, 2020. Mandatory […]

Learn More
340B Update 7.20

Drug companies take action in light of changes to the 340B Drug Program

Merck & Co. is communicating directly with covered entities asking for contract pharmacy claim data to be submitted to Merck via a secure web portal. Merck states the data will […]

Learn More
HRSA Now Allows Accelerated Timelines for Offsite Locations

HRSA Now Allows Accelerated Timelines for Offsite Locations

HRSA has indicated it will allow a hospital to accelerate timelines for its offsite locations to begin participating in the 340B Drug Discount Program. Previously, offsite locations were required to […]

Learn More
CMS 340B Hospital Drug Cost Survey Due May 15, 2020

CMS 340B Hospital Drug Cost Survey Due May 15, 2020

The White House Office of Management and Budget (OMB) approved the Centers for Medicare & Medicaid Services’ (CMS) plan, proposed September 30, 2019, to survey 340B hospitals for their net […]

Learn More
COVID-19 and the Impact on 340B

COVID-19 and the Impact on 340B

This article was originally published on March 25th and was updated on April 23rd. It is being updated as new information becomes available. We wanted to provide updates on the […]

Learn More
Delayed Implementation of Required 340B Modifiers_ KY Department of Medicaid Services

Delayed Implementation of Required 340B Modifiers: KY Department of Medicaid Services

We wanted to share an urgent update on the impending billing changes that were scheduled to take effect on 4/1/2020. In a communication we acquired today from Jessin Joseph, Pharmacy […]

Learn More
340B Recertification Reminder

340B Recertification Reminder

Consolidated Health Center & FQHC Look-a-Likes The 2020 Grantee recertification period for Consolidated Health Centers, Federal Qualified Health Center Look-Alikes, Ryan White, Comprehensive Hemophilia Treatment Centers, Native Hawaiian, Black Lung […]

Learn More
Hospital 340B Recertification Scheduled to Begin on Aug. 19

Hospital 340B Recertification Scheduled to Begin on August 19

The Health Resources and Services Administration (HRSA) has set the annual recertification of eligibility for 340B drug discounts for hospitals to begin August 19, 2019, and end September 16, 2019. […]

Learn More
New Requirements by Anthem for 340B Participants

New Requirements by Anthem for 340B Participants

Attention 340B covered entities participating with Anthem Blue Cross and Blue Shield: Effective April 1, 2019, Anthem requires that a “JG,” “TB,” or another relevant modifier be added to claims […]

Learn More
New Requirements by Humana for 340B Participants

New Requirements by Humana for 340B Participants

Attention 340B covered entities participating with Humana – Managed Care Medicare: Effective January 1, 2019, Humana requires that a “JG,” “TB,” or another relevant modifier be added to claims involving […]

Learn More
U.S. District Judge Rules 340B Cuts Exceeded HHS Authority

U.S. District Judge Rules 340B Cuts Exceeded HHS Authority

On December 28, 2018, a federal judge in Washington reversed the enormous cuts to Medicare OP Drug payments implemented by CMS which were effective January 1, 2018. U.S. District Judge Rudolph […]

Learn More
Leveraging 340B Compliance to Improve Profitability

Leveraging 340B Compliance to Improve Profitability

Compliance is often a misunderstood word that most healthcare professionals associate with spending more time and money. Typically, compliance is defined as a certification or confirmation that the doer of […]

Learn More

Webinars

340B Recertification Window Now Open: Reminder for Hospitals

The Health Resources and Services Administration (HRSA) has set the annual recertification window for the 340B Drug Pricing Program for hospitals from August 12, 2024 to September 9, 2024. The […]

Learn More

340B Recertification Reminder for Consolidated Health Centers & FQHC Look-a-Likes

This is your 340B recertification reminder for 2024. The 2024 Grantee recertification period for Consolidated Health Centers, Federal Qualified Health Center Look-Alikes, Ryan White, Comprehensive Hemophilia Treatment Centers, Native Hawaiian, […]

Learn More

Final Hospital 340B Outpatient Prospective Payment System (OPPS) Remedy

On November 2, 2023, the Centers for Medicare & Medicaid Services (CMS) released a final rule around the 340B outpatient prospective payment system (OPPS), outlining a plan to correct and […]

Learn More

Proposed 340B Outpatient Prospective Payment System (OPPS) Solution

On Friday July 7th, 2023, CMS released a proposed rule outlining a plan to correct and reverse the 340B payment cuts from calendar years (CY) 2018 through 2022, including a […]

Learn More

340B Medicare Reimbursement Adjustments

Great news for 340B hospitals impacted by the reimbursement reductions initiated by the Center for Medicare and Medicaid Services (CMS) on January 1, 2018. Recently, CMS announced that the 2023 […]

Learn More

340B Hospitals Impacted by Supreme Court Decision

In June, the Supreme Court gave hospitals participating in the 340B Drug Pricing Program a convincing victory ruling unanimously that the U.S. Center for Medicare & Medicaid Services (CMS) should […]

Learn More